AIXA.DEAIXA.DEXETRA
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -9.67% |
| Q3 2025 | 28.98% |
| Q2 2025 | 4.01% |
| Q1 2025 | -22.05% |
| Q4 2024 | 6.85% |
| Q3 2024 | -13.69% |
| Q2 2024 | 7.09% |
| Q1 2024 | -17.78% |
| Q4 2023 | 33.99% |
| Q3 2023 | 5.14% |
| Q2 2023 | 3.38% |
| Q1 2023 | 16.99% |
| Q4 2022 | 16.81% |
| Q3 2022 | 6.03% |
| Q2 2022 | -6.32% |
| Q1 2022 | -11.64% |
| Q4 2021 | 16.26% |
| Q3 2021 | -7.66% |
| Q2 2021 | 25.40% |
| Q1 2021 | -30.97% |
| Q4 2020 | 36.90% |
| Q3 2020 | -11.68% |
| Q2 2020 | -1.44% |
| Q1 2020 | -3.60% |
| Q4 2019 | 2.00% |
| Q3 2019 | 16.94% |
| Q2 2019 | -1.90% |
| Q1 2019 | 5.01% |
| Q4 2018 | -6.83% |
| Q3 2018 | -1.26% |
| Q2 2018 | -3.58% |
| Q1 2018 | -16.92% |
| Q4 2017 | 29.02% |
| Q3 2017 | -35.31% |
| Q2 2017 | 0.64% |
| Q1 2017 | 36.96% |
| Q4 2016 | 5.82% |
| Q3 2016 | 7.13% |
| Q2 2016 | -5.04% |
| Q1 2016 | -7.08% |